G

GEn1E Lifesciences Inc.

15 employees

GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Multi-target
Next-generation
AI Platform
Artificial Intelligence
Rare Diseases
Inflammation
Y Combinator
Pharmaceutical
Drug Discovery
Machine Learning
Clinical Stage
Health Care
Inflammatory Disease
Novel Drugs
Techbio
Drug Development
Immunomodulators
ARDS
Life Science

Date founded

2018

Funding rounds raised

G

GEn1E Lifesciences Inc. raised undisclosed on August 2, 2021

Investors: 10X Capital

G

GEn1E Lifesciences Inc. raised undisclosed on January 27, 2021

Investors: Bossa Nova Investimentos, Stanford Angels & Entrepreneurs and 10X Capital

G

GEn1E Lifesciences Inc. raised undisclosed on February 12, 2020

Investors: Harmonix

G

GEn1E Lifesciences Inc. raised undisclosed on August 22, 2019

Investors: K G Khosla compressors and Y Combinator

FAQ